[Progress in the therapy of medulloblastoma].
The nearly exclusive metastatic spread of the radiosensitive medulloblastoma into the fluid spaces of the liquor system allows a curative therapeutic attempt by a systemic radiation. The actual 5-years survival rate is about 40%. It should be possible to improve it to up to 50% by consequently applicating radiotherapy. A prospective study concerning the possibilities of chemotherapy presently underway, does not yet permit a definite statement. The most essential complication after radiotherapy of children concerns the symmetric reduction of growth.
D001932:Brain Neoplasms / Q000601:surgery*; D002555:Cerebrospinal Fluid / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D008527:Medulloblastoma / Q000532:radiotherapy*; D009362:Neoplasm Metastasis; D011379:Prognosis; D011878:Radiotherapy / Q000009:adverse effects
Fortschritte in der Therapie des Medulloblastoms.